Recently, numerous studies have found that blood biomarkers, including Aβ40, Aβ42, T-tau, P-tau181, etc., are closely associated with the onset of AD, thereby indicating the feasibility of diagnosing AD [5,6,7]. This evidence concerns the gene MAPT and Alzheimer disease.